CAPS Rating: 2 out of 5

A biopharmaceutical company, which focused on developing and commercializing novel pain management therapies.


Player Avatar pennysplants (99.54) Submitted: 9/5/2007 5:55:00 PM : Outperform Start Price: $7.76 NGSX Score: -90.63

NGSX has been on my watch list for ages, but was under the 100m market cap. So, I had to sit on my hands.

With phase 3 trial "results" announced yesterday, it's now "pickable". [And no, I don't hate myself in the mirror today. It's the 24 hour delay thing. I would have rather bought yesterday].

Pain patch. Chili peppers (don't laugh -- I'm a believer). Sufficient cash on hand to commercialize... or at least get er go'n.

AND, the head honcho made "the" look like monkeys. I know that may not be hard to do ... but it's done so infrequently ... as to merit some notice.

Anyway, NGSX is for the speculative small cap portion of my portfolio. Hope it doesn't get bought out too soon.

Report this Post 2 Replies
Member Avatar pennysplants (99.54) Submitted: 2/28/2008 4:01:04 PM
Recs: 0

Don't give up on this one yet. Big looser today on trial results. But, after digging underneath the headlines, I'm inclined to hang tight. Risky, yes. But, I already made my calculated wager. Don't blink now. This represents only a small portion of my speculative portfolio.

Member Avatar pennysplants (99.54) Submitted: 11/22/2012 10:41:37 AM
Recs: 0

Oh well. Cleaning up after 2 year hiatus on CAPS

Featured Broker Partners